Ignite Creation Date:
2024-05-06 @ 6:30 PM
Last Modification Date:
2025-12-17 @ 12:52 PM
Study NCT ID:
NCT05689203
Status:
None
Last Update Posted:
2023-01-19 00:00:00
First Post:
2023-01-15 00:00:00
Brief Title:
A Phase 2 Study to Evaluate the Efficacy and Safety of QLS1128 Orally in Symptomatic Participants With Mild to Moderate COVID-19
Sponsor:
Qilu Pharmaceutical Co Ltd
Organization:
Qilu Pharmaceutical Co., Ltd.
Conditions & Keywords Data
Conditions:
| Name |
|---|
| COVID-19 |
Keywords: